Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03565640 · ClinicalTrials.gov registry record · NA
Anchorsure Versus Capio for Sacrospinous Ligament Fixation
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT03565640 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 48 participants.
The verdict
NCT03565640, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
Sacrospinous ligament fixation is a common method of repairing apical support for pelvic organ prolapse but it currently suffers from a high rate of postoperative buttock and posterior thigh pain. Anchorsure® is a relatively new FDA-approved device that uses an anchor instead of the widely-used suture capturing mechanism to perform sacrospinous ligament fixation. The study hypothesis is that Anchorsure® will reduce the degree and rate of buttock and posterior thigh pain compared to the widely used Capio™ Slim suturing capturing Device.
Interventions
- DEVICE Capio Slim Device
- DEVICE Anchorsure Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2018-10-29 |
| Est. Completion | 2022-01-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03565640
The ClinicalTrials.gov registry entry for NCT03565640 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Capio Slim Device is the first listed.
NCT03565640 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03565640 about?
NCT03565640 is a clinical study titled "Anchorsure Versus Capio for Sacrospinous Ligament Fixation". Sacrospinous ligament fixation is a common method of repairing apical support for pelvic organ prolapse but it currently suffers from a high rate of postoperative buttock and posterior thigh pain. Anchorsure® is a relatively new FDA-approved device that uses an anchor instead of the widely-used sutu...
What is the current status of trial NCT03565640?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2018-10-29. Estimated completion is 2022-01-26.
What interventions are being tested in trial NCT03565640?
The interventions under investigation include: Capio Slim Device (DEVICE), Anchorsure Device (DEVICE).
Who is sponsoring clinical trial NCT03565640?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.